tiprankstipranks
Trending News
More News >
NEXUS AG (GB:0FGL)
:0FGL
Advertisement

NEXUS AG (0FGL) Price & Analysis

Compare
0 Followers

0FGL Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

3.95%96.05%
Insiders
3.95%
Mutual Funds
― Other Institutional Investors
96.05% Public Companies and
Individual Investors

0FGL FAQ

What was NEXUS AG’s price range in the past 12 months?
NEXUS AG lowest share price was €47.40 and its highest was €74.50 in the past 12 months.
    What is NEXUS AG’s market cap?
    NEXUS AG’s market cap is €1.22B.
      When is NEXUS AG’s upcoming earnings report date?
      NEXUS AG’s upcoming earnings report date is Aug 12, 2025 which is in 24 days.
        How were NEXUS AG’s earnings last quarter?
        Currently, no data Available
        Is NEXUS AG overvalued?
        According to Wall Street analysts NEXUS AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does NEXUS AG pay dividends?
          NEXUS AG pays a Annually dividend of €0.23 which represents an annual dividend yield of 0.33%. See more information on NEXUS AG dividends here
            What is NEXUS AG’s EPS estimate?
            NEXUS AG’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does NEXUS AG have?
            NEXUS AG has 17,274,694 shares outstanding.
              What happened to NEXUS AG’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of NEXUS AG?
              Currently, no hedge funds are holding shares in GB:0FGL

              Company Description

              NEXUS AG

              Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.
              Similar Stocks
              Company
              Price & Change
              Follow
              CompuGroup Medical
              MeVis Medical Solutions
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis